文献速递神经肿瘤

2000至2013年美国少突胶质细胞瘤与间变性少突胶质细胞瘤的发病率和生存趋势:CBTRUS报告

Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report.
PubMed 文献 · J Neurooncol · 2017-04-10

基于美国脑肿瘤登记中心(CBTRUS)2000至2013年数据,分析少突胶质细胞瘤(OD)与间变性少突胶质细胞瘤(AOD)的年龄、性别和种族发病趋势及生存率。OD和AOD发病率分别于36-40岁和56-60岁达峰,AOD与OD比值随年龄增长至75岁升高;总体发病率下降(OD年度变化百分比APC为-3.2,AOD为-6.5),白人OD发病率最高但显著下降(APC -3.1),黑人下降不显著(APC -1.6);OD生存率随年龄增长下降,而AOD在0-24岁人群生存率最低。

要点

  • OD和AOD发病率分别在36-40岁和56-60岁达峰,AOD与OD比值随年龄增长至75岁升高。
  • OD总体APC为-3.2(2000-2013),AOD为-6.5(2000-2007)。
  • 白人OD发病率最高但显著下降(APC -3.1),黑人下降不显著(APC -1.6)。

核心结论

  • 2000至2013年美国OD和AOD总体发病率下降,AOD在75岁前占少突胶质细胞肿瘤比例增加,0-24岁AOD生存率较低可能提示儿童病例存在分子差异。

研究设计与样本

  • 分析美国脑肿瘤登记中心(CBTRUS)2000至2013年数据,计算年龄、性别和种族的年龄调整发病率(每10万人年,含95%CI)和年度变化百分比(APC,含95%CI),生存率基于CBTRUS数据子集计算。

主要发现

  • OD和AOD发病年龄峰值分别为36-40岁和56-60岁,AOD与OD比值随年龄增长至75岁升高。
  • OD总体APC为-3.2(2000-2013),AOD为-6.5(2000-2007)。
  • 白人OD发病率最高但显著下降(2000-2013年APC -3.1),黑人下降不显著(2000-2013年APC -1.6)。
  • OD生存率随年龄增长下降,AOD在0-24岁人群生存率最低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Measuring tumor-specific trends in incidence is necessary to elucidate tumor-type contribution to overall cancer burden in the US population. Recently, there have been conflicting reports concerning the incidence of oligodendrogliomas (OD) and anaplastic oligodendrogliomas (AOD). Therefore, our goal was to examine trends in OD and AOD incidence and survival by age, gender and race. Data was analyzed from the Central Brain Tumor Registry of the United States (CBTRUS) from 2000 to 2013. Age-adjusted incidence rates per 100,000 person-years with 95% confidence intervals (CI) and annual percent changes (APCs) with 95% CI were calculated for OD and AOD by age, sex and race. Survival rates were calculated for age, sex and race using a subset of the CBTRUS data. OD and AOD incidence peaked at 36-40 and 56-60 years, respectively. AOD:OD ratio increased up to age 75. Overall, OD and AOD incidence decreased [OD: APC -3.2 (2000-2013), AOD: -6.5 (2000-2007)]. OD incidence was highest in Whites but decreased significantly (2000-2013: APC -3.1) while incidence in Black populations did not significantly decrease (2000-2013: APC -1.6). Survival rates decreased with advancing age for OD, while persons aged 0-24 had the lowest survival for AOD. The current study reports a decrease in overall OD and AOD incidence from 2000 to 2013. Furthermore, AOD makes up an increasing proportion of oligodendroglial tumors up to age 75. Lower AOD survival in 0-24 years old may indicate molecular differences in pediatric cases. Thus, surveillance of tumor-specific trends by age, race and sex can reveal clinically relevant variations.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Achey RL, Khanna V, Ostrom QT, et al. Incidence and survival trends in oligodendrogliomas and anaplastic oligodendrogliomas in the United States from 2000 to 2013: a CBTRUS Report. J Neurooncol. 2017. PMID: 28397028. doi:10.1007/s11060-017-2414-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。